{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:23:43Z","timestamp":1786508623349,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.annepidem.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T09:48:31Z","timestamp":1626601711000},"page":"22-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Using marginal structural models to analyze randomized clinical trials with non-adherence and lost to follow up"],"prefix":"10.1016","volume":"63","author":[{"given":"Elizabeth A.","family":"Lancet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa N.","family":"Borrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Morabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.annepidem.2021.07.001_bib0001","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1740774511420743","article-title":"Beyond the intention-to-treat in comparative effectiveness research","volume":"9","author":"Hern\u00e1n","year":"2012","journal-title":"Clin Trials"},{"issue":"2","key":"10.1016\/j.annepidem.2021.07.001_bib0002","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2125.2002.01628.x","article-title":"Is intent-to-treat analysis always (ever) enough?","volume":"54","author":"Sheiner","year":"2002","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.annepidem.2021.07.001_bib0003","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"8","key":"10.1016\/j.annepidem.2021.07.001_bib0004","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-159-8-201310150-00709","article-title":"Randomized trials analyzed as observational studies","volume":"159","author":"Hern\u00e1n","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annepidem.2021.07.001_bib0005","series-title":"Longitudinal data analysis","first-page":"553","article-title":"Estimation of the causal effects of time-varying exposures","author":"Robins","year":"2009"},{"issue":"10","key":"10.1016\/j.annepidem.2021.07.001_bib0006","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/aje\/kwh131","article-title":"Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology","volume":"159","author":"Bodnar","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.annepidem.2021.07.001_bib0007","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/sim.1144","article-title":"Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures","volume":"21","author":"Hern\u00e1n","year":"2002","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.annepidem.2021.07.001_bib0008","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/sim.3801","article-title":"Missing data in the exposure of interest and marginal structural models: a simulation study based on the framingham heart study","volume":"29","author":"Shortreed","year":"2010","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.annepidem.2021.07.001_bib0009","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1037\/a0022610","article-title":"A marginal structural model analysis for loneliness: implications for intervention trials and clinical practice","volume":"79","author":"VanderWeele","year":"2011","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"10.1016\/j.annepidem.2021.07.001_bib0010","doi-asserted-by":"crossref","first-page":"Article 22","DOI":"10.2202\/1557-4679.1117","article-title":"Causal inference from longitudinal studies with baseline randomization","volume":"4","author":"Toh","year":"2008","journal-title":"Int J Biostat"},{"issue":"6","key":"10.1016\/j.annepidem.2021.07.001_bib0011","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2021.07.001_bib0012","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.conctc.2016.10.005","article-title":"Application of the marginal structural model to account for suboptimal adherence in a randomized controlled trial","volume":"4","author":"Rochon","year":"2016","journal-title":"Contemp Clin Trials Commun"},{"issue":"3","key":"10.1016\/j.annepidem.2021.07.001_bib0013","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1164\/rccm.200603-416OC","article-title":"Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma","volume":"175","author":"The American Lung Association Asthma Clinical Research","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.annepidem.2021.07.001_bib0014","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13665-012-0024-y","article-title":"Asthma clinical trials of American lung association\/asthma clinical research centers (ALA-ACRC): what have we learned in 12 years?","volume":"1","author":"Sumino","year":"2012","journal-title":"Curr Respir Care Rep"},{"issue":"3 Suppl","key":"10.1016\/j.annepidem.2021.07.001_bib0015","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaci.2011.12.986","article-title":"Asthma outcomes: pulmonary physiology","volume":"129","author":"Tepper","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"10 Supl 2","key":"10.1016\/j.annepidem.2021.07.001_bib0016","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1097\/MLR.0b013e31806518ac","article-title":"Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases","volume":"45","author":"Curtis","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.annepidem.2021.07.001_bib0017","unstructured":"Crowson C.S., Schenck L.A., Green A.B., Atkinson E.J., Therneau T.M. The basics of propensity scoring and marginal structural models. Mayo Clinic Technical Report #84, August 1, 2013. http:\/\/www.mayo.edu\/research\/documents\/biostat-84-pdf\/doc-20024406."},{"key":"10.1016\/j.annepidem.2021.07.001_bib0018","series-title":"Causal Inference","article-title":"Causal inference. chapman & hall\/crc, forthcoming","author":"Hern\u00e1n","year":"2018"},{"key":"10.1016\/j.annepidem.2021.07.001_bib0019","series-title":"Analysis of Observational Health Care Data Using SAS\u00ae","first-page":"211","article-title":"Analysis of longitudinal observational data using marginal structural models","author":"Faries","year":"2010"},{"issue":"1","key":"10.1016\/j.annepidem.2021.07.001_bib0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/2167696815621645","article-title":"A primer on inverse probability of treatment weighting and marginal structural models","volume":"4","author":"Thoemmes","year":"2016","journal-title":"Emerging Adulthood"},{"key":"10.1016\/j.annepidem.2021.07.001_bib0021","series-title":"Applied longitudinal data analysis for epidemiology: a practical guide","author":"Twisk","year":"2013"},{"key":"10.1016\/j.annepidem.2021.07.001_bib0022","series-title":"Applied regression analysis and generalized linear models.","article-title":"Applied regression analysis and generalized linear models. second edi","author":"Fox","year":"2008"},{"key":"10.1016\/j.annepidem.2021.07.001_bib0023","series-title":"An introduction to generalized linear models","author":"Dobson","year":"2002"},{"key":"10.1016\/j.annepidem.2021.07.001_bib0024","article-title":"SAS 9.4","year":"2018","journal-title":"Copyright \u00a9"},{"issue":"2","key":"10.1016\/j.annepidem.2021.07.001_bib0025","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/biostatistics\/kxq054","article-title":"Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial","volume":"12","author":"Zhang","year":"2011","journal-title":"Biostatistics"},{"issue":"12","key":"10.1016\/j.annepidem.2021.07.001_bib0026","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/sim.3585","article-title":"Inverse probability-of-censoring weights for the correction of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident AIDS or death","volume":"28","author":"Cain","year":"2009","journal-title":"Stat Med"},{"issue":"11","key":"10.1016\/j.annepidem.2021.07.001_bib0027","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/aje\/155.11.1045","article-title":"Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians\u2019 Health Study","volume":"155","author":"Cook","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2021.07.001_bib0028","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/EDE.0b013e3181df1b69","article-title":"Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization","volume":"21","author":"Toh","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.annepidem.2021.07.001_bib0029","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women\u2019s health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279721002052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279721002052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:27:03Z","timestamp":1760927223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279721002052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":29,"alternative-id":["S1047279721002052"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2021.07.001","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using marginal structural models to analyze randomized clinical trials with non-adherence and lost to follow up","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}